Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies

F. Pacini, F. Basolo, R. Bellantone, G. Boni, M.A. Cannizzaro, M. De Palma, C. Durante, R. Elisei, G. Fadda, A. Frasoldati, L. Fugazzola, R. Guglielmi, C.P. Lombardi, P. Miccoli, E. Papini, G. Pellegriti, L. Pezzullo, A. Pontecorvi, M. Salvatori, E. SeregniP. Vitti

Research output: Contribution to journalArticle

Abstract

Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Methods: Six scientific Italian societies entitled to cure thyroid cancer patients (the Italian Thyroid Association, the Medical Endocrinology Association, the Italian Society of Endocrinology, the Italian Association of Nuclear Medicine and Molecular Imaging, the Italian Society of Unified Endocrine Surgery and the Italian Society of Anatomic Pathology and Diagnostic Cytology) felt the need to develop a consensus report based on significant scientific advances occurred in the field. Objective: The document includes recommendations regarding initial evaluation of thyroid nodules, clinical and ultrasound criteria for fine-needle aspiration biopsy, initial management of thyroid cancer including staging and risk assessment, surgical management, radioiodine remnant ablation, and levothyroxine therapy, short-term and long-term follow-up strategies, and management of recurrent and metastatic disease. The objective of this consensus is to inform clinicians, patients, researchers, and health policy makers about the best strategies (and their limitations) relating to the diagnosis and treatment of differentiated thyroid cancer. © 2018, Italian Society of Endocrinology (SIE).
Original languageEnglish
Pages (from-to)849-876
Number of pages28
JournalJournal of Endocrinological Investigation
Volume41
Issue number7
DOIs
Publication statusPublished - 2018

Fingerprint

Thyroid Neoplasms
Endocrinology
Thyroid Nodule
Molecular Imaging
Neoplasm Staging
Nuclear Medicine
Therapeutics
Fine Needle Biopsy
Health Policy
Administrative Personnel
Thyroxine
Cell Biology
Thyroid Gland
Research Personnel
Pathology

Keywords

  • iodine 131
  • lenvatinib
  • levothyroxine
  • radioactive iodine
  • sorafenib, Article
  • cancer diagnosis
  • cancer patient
  • cancer recurrence
  • cancer staging
  • cancer therapy
  • clinical feature
  • consensus
  • differentiated thyroid cancer
  • echography
  • fine needle aspiration biopsy
  • follow up
  • human
  • Italy
  • medical society
  • metastasis
  • practice guideline
  • risk assessment
  • thyroid nodule
  • adenocarcinoma
  • endocrinology
  • molecular imaging
  • nuclear medicine
  • organization and management
  • procedures
  • scintiscanning
  • standards
  • thyroid tumor, Adenocarcinoma
  • Biopsy, Fine-Needle
  • Consensus
  • Endocrinology
  • Humans
  • Molecular Imaging
  • Nuclear Medicine
  • Radionuclide Imaging
  • Societies, Medical
  • Thyroid Neoplasms
  • Ultrasonography

Cite this

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. / Pacini, F.; Basolo, F.; Bellantone, R.; Boni, G.; Cannizzaro, M.A.; De Palma, M.; Durante, C.; Elisei, R.; Fadda, G.; Frasoldati, A.; Fugazzola, L.; Guglielmi, R.; Lombardi, C.P.; Miccoli, P.; Papini, E.; Pellegriti, G.; Pezzullo, L.; Pontecorvi, A.; Salvatori, M.; Seregni, E.; Vitti, P.

In: Journal of Endocrinological Investigation, Vol. 41, No. 7, 2018, p. 849-876.

Research output: Contribution to journalArticle

Pacini, F, Basolo, F, Bellantone, R, Boni, G, Cannizzaro, MA, De Palma, M, Durante, C, Elisei, R, Fadda, G, Frasoldati, A, Fugazzola, L, Guglielmi, R, Lombardi, CP, Miccoli, P, Papini, E, Pellegriti, G, Pezzullo, L, Pontecorvi, A, Salvatori, M, Seregni, E & Vitti, P 2018, 'Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies', Journal of Endocrinological Investigation, vol. 41, no. 7, pp. 849-876. https://doi.org/10.1007/s40618-018-0884-2
Pacini, F. ; Basolo, F. ; Bellantone, R. ; Boni, G. ; Cannizzaro, M.A. ; De Palma, M. ; Durante, C. ; Elisei, R. ; Fadda, G. ; Frasoldati, A. ; Fugazzola, L. ; Guglielmi, R. ; Lombardi, C.P. ; Miccoli, P. ; Papini, E. ; Pellegriti, G. ; Pezzullo, L. ; Pontecorvi, A. ; Salvatori, M. ; Seregni, E. ; Vitti, P. / Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. In: Journal of Endocrinological Investigation. 2018 ; Vol. 41, No. 7. pp. 849-876.
@article{5ad5f47eeee64bbfbdaac5fffa18a770,
title = "Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies",
abstract = "Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Methods: Six scientific Italian societies entitled to cure thyroid cancer patients (the Italian Thyroid Association, the Medical Endocrinology Association, the Italian Society of Endocrinology, the Italian Association of Nuclear Medicine and Molecular Imaging, the Italian Society of Unified Endocrine Surgery and the Italian Society of Anatomic Pathology and Diagnostic Cytology) felt the need to develop a consensus report based on significant scientific advances occurred in the field. Objective: The document includes recommendations regarding initial evaluation of thyroid nodules, clinical and ultrasound criteria for fine-needle aspiration biopsy, initial management of thyroid cancer including staging and risk assessment, surgical management, radioiodine remnant ablation, and levothyroxine therapy, short-term and long-term follow-up strategies, and management of recurrent and metastatic disease. The objective of this consensus is to inform clinicians, patients, researchers, and health policy makers about the best strategies (and their limitations) relating to the diagnosis and treatment of differentiated thyroid cancer. {\circledC} 2018, Italian Society of Endocrinology (SIE).",
keywords = "iodine 131, lenvatinib, levothyroxine, radioactive iodine, sorafenib, Article, cancer diagnosis, cancer patient, cancer recurrence, cancer staging, cancer therapy, clinical feature, consensus, differentiated thyroid cancer, echography, fine needle aspiration biopsy, follow up, human, Italy, medical society, metastasis, practice guideline, risk assessment, thyroid nodule, adenocarcinoma, endocrinology, molecular imaging, nuclear medicine, organization and management, procedures, scintiscanning, standards, thyroid tumor, Adenocarcinoma, Biopsy, Fine-Needle, Consensus, Endocrinology, Humans, Molecular Imaging, Nuclear Medicine, Radionuclide Imaging, Societies, Medical, Thyroid Neoplasms, Ultrasonography",
author = "F. Pacini and F. Basolo and R. Bellantone and G. Boni and M.A. Cannizzaro and {De Palma}, M. and C. Durante and R. Elisei and G. Fadda and A. Frasoldati and L. Fugazzola and R. Guglielmi and C.P. Lombardi and P. Miccoli and E. Papini and G. Pellegriti and L. Pezzullo and A. Pontecorvi and M. Salvatori and E. Seregni and P. Vitti",
note = "cited By 5",
year = "2018",
doi = "10.1007/s40618-018-0884-2",
language = "English",
volume = "41",
pages = "849--876",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "7",

}

TY - JOUR

T1 - Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies

AU - Pacini, F.

AU - Basolo, F.

AU - Bellantone, R.

AU - Boni, G.

AU - Cannizzaro, M.A.

AU - De Palma, M.

AU - Durante, C.

AU - Elisei, R.

AU - Fadda, G.

AU - Frasoldati, A.

AU - Fugazzola, L.

AU - Guglielmi, R.

AU - Lombardi, C.P.

AU - Miccoli, P.

AU - Papini, E.

AU - Pellegriti, G.

AU - Pezzullo, L.

AU - Pontecorvi, A.

AU - Salvatori, M.

AU - Seregni, E.

AU - Vitti, P.

N1 - cited By 5

PY - 2018

Y1 - 2018

N2 - Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Methods: Six scientific Italian societies entitled to cure thyroid cancer patients (the Italian Thyroid Association, the Medical Endocrinology Association, the Italian Society of Endocrinology, the Italian Association of Nuclear Medicine and Molecular Imaging, the Italian Society of Unified Endocrine Surgery and the Italian Society of Anatomic Pathology and Diagnostic Cytology) felt the need to develop a consensus report based on significant scientific advances occurred in the field. Objective: The document includes recommendations regarding initial evaluation of thyroid nodules, clinical and ultrasound criteria for fine-needle aspiration biopsy, initial management of thyroid cancer including staging and risk assessment, surgical management, radioiodine remnant ablation, and levothyroxine therapy, short-term and long-term follow-up strategies, and management of recurrent and metastatic disease. The objective of this consensus is to inform clinicians, patients, researchers, and health policy makers about the best strategies (and their limitations) relating to the diagnosis and treatment of differentiated thyroid cancer. © 2018, Italian Society of Endocrinology (SIE).

AB - Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Methods: Six scientific Italian societies entitled to cure thyroid cancer patients (the Italian Thyroid Association, the Medical Endocrinology Association, the Italian Society of Endocrinology, the Italian Association of Nuclear Medicine and Molecular Imaging, the Italian Society of Unified Endocrine Surgery and the Italian Society of Anatomic Pathology and Diagnostic Cytology) felt the need to develop a consensus report based on significant scientific advances occurred in the field. Objective: The document includes recommendations regarding initial evaluation of thyroid nodules, clinical and ultrasound criteria for fine-needle aspiration biopsy, initial management of thyroid cancer including staging and risk assessment, surgical management, radioiodine remnant ablation, and levothyroxine therapy, short-term and long-term follow-up strategies, and management of recurrent and metastatic disease. The objective of this consensus is to inform clinicians, patients, researchers, and health policy makers about the best strategies (and their limitations) relating to the diagnosis and treatment of differentiated thyroid cancer. © 2018, Italian Society of Endocrinology (SIE).

KW - iodine 131

KW - lenvatinib

KW - levothyroxine

KW - radioactive iodine

KW - sorafenib, Article

KW - cancer diagnosis

KW - cancer patient

KW - cancer recurrence

KW - cancer staging

KW - cancer therapy

KW - clinical feature

KW - consensus

KW - differentiated thyroid cancer

KW - echography

KW - fine needle aspiration biopsy

KW - follow up

KW - human

KW - Italy

KW - medical society

KW - metastasis

KW - practice guideline

KW - risk assessment

KW - thyroid nodule

KW - adenocarcinoma

KW - endocrinology

KW - molecular imaging

KW - nuclear medicine

KW - organization and management

KW - procedures

KW - scintiscanning

KW - standards

KW - thyroid tumor, Adenocarcinoma

KW - Biopsy, Fine-Needle

KW - Consensus

KW - Endocrinology

KW - Humans

KW - Molecular Imaging

KW - Nuclear Medicine

KW - Radionuclide Imaging

KW - Societies, Medical

KW - Thyroid Neoplasms

KW - Ultrasonography

U2 - 10.1007/s40618-018-0884-2

DO - 10.1007/s40618-018-0884-2

M3 - Article

VL - 41

SP - 849

EP - 876

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 7

ER -